1-235380161-TTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG-TTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTG
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_003193.5(TBCE):c.100+64_100+65dupGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.019 ( 32 hom., cov: 0)
Exomes 𝑓: 0.0045 ( 0 hom. )
Consequence
TBCE
NM_003193.5 intron
NM_003193.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.401
Publications
1 publications found
Genes affected
TBCE (HGNC:11582): (tubulin folding cofactor E) Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
TBCE Gene-Disease associations (from GenCC):
- hypoparathyroidism-retardation-dysmorphism syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
- early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndromeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- encephalopathy, progressive, with amyotrophy and optic atrophyInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P
- autosomal recessive Kenny-Caffey syndromeInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP6
Variant 1-235380161-T-TTG is Benign according to our data. Variant chr1-235380161-T-TTG is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 296289.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0191 (2678/139848) while in subpopulation NFE AF = 0.0276 (1777/64456). AF 95% confidence interval is 0.0265. There are 32 homozygotes in GnomAd4. There are 1206 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 32 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TBCE | NM_003193.5 | c.100+64_100+65dupGT | intron_variant | Intron 2 of 16 | ENST00000642610.2 | NP_003184.1 | ||
| TBCE | NM_001287801.2 | c.100+64_100+65dupGT | intron_variant | Intron 2 of 17 | NP_001274730.1 | |||
| TBCE | NM_001079515.3 | c.100+64_100+65dupGT | intron_variant | Intron 2 of 16 | NP_001072983.1 | |||
| TBCE | NM_001287802.2 | c.-211+64_-211+65dupGT | intron_variant | Intron 2 of 15 | NP_001274731.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TBCE | ENST00000642610.2 | c.100+12_100+13insTG | intron_variant | Intron 2 of 16 | NM_003193.5 | ENSP00000494796.1 | ||||
| ENSG00000285053 | ENST00000647186.1 | c.100+12_100+13insTG | intron_variant | Intron 4 of 18 | ENSP00000494775.1 |
Frequencies
GnomAD3 genomes AF: 0.0192 AC: 2676AN: 139726Hom.: 32 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
2676
AN:
139726
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00445 AC: 4436AN: 996812Hom.: 0 Cov.: 0 AF XY: 0.00463 AC XY: 2367AN XY: 510910 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
4436
AN:
996812
Hom.:
Cov.:
0
AF XY:
AC XY:
2367
AN XY:
510910
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
36
AN:
25156
American (AMR)
AF:
AC:
215
AN:
41510
Ashkenazi Jewish (ASJ)
AF:
AC:
86
AN:
21080
East Asian (EAS)
AF:
AC:
116
AN:
33962
South Asian (SAS)
AF:
AC:
362
AN:
74688
European-Finnish (FIN)
AF:
AC:
235
AN:
46380
Middle Eastern (MID)
AF:
AC:
19
AN:
4502
European-Non Finnish (NFE)
AF:
AC:
3144
AN:
706278
Other (OTH)
AF:
AC:
223
AN:
43256
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.322
Heterozygous variant carriers
0
307
614
920
1227
1534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0191 AC: 2678AN: 139848Hom.: 32 Cov.: 0 AF XY: 0.0180 AC XY: 1206AN XY: 67078 show subpopulations
GnomAD4 genome
AF:
AC:
2678
AN:
139848
Hom.:
Cov.:
0
AF XY:
AC XY:
1206
AN XY:
67078
show subpopulations
African (AFR)
AF:
AC:
262
AN:
38350
American (AMR)
AF:
AC:
309
AN:
13500
Ashkenazi Jewish (ASJ)
AF:
AC:
39
AN:
3312
East Asian (EAS)
AF:
AC:
66
AN:
4748
South Asian (SAS)
AF:
AC:
46
AN:
4084
European-Finnish (FIN)
AF:
AC:
135
AN:
8336
Middle Eastern (MID)
AF:
AC:
3
AN:
278
European-Non Finnish (NFE)
AF:
AC:
1777
AN:
64456
Other (OTH)
AF:
AC:
35
AN:
1906
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.455
Heterozygous variant carriers
0
101
202
302
403
504
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hypoparathyroidism-retardation-dysmorphism syndrome Uncertain:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Oct 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.